Publicaciones en colaboración con investigadores/as de Charité (6)

2020

  1. Sarcoma treatment in the era of molecular medicine

    EMBO Molecular Medicine, Vol. 12, Núm. 11

2016

  1. Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/TRAIL-Cisplatin combination therapy in cervical cancer

    Genes Chromosomes and Cancer, Vol. 55, Núm. 2, pp. 177-189

2009

  1. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer

    Genes Chromosomes and Cancer, Vol. 48, Núm. 11, pp. 983-992

2008

  1. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression

    Genes Chromosomes and Cancer, Vol. 47, Núm. 9, pp. 755-765

2007

  1. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes

    Genes Chromosomes and Cancer, Vol. 46, Núm. 4, pp. 373-384

2006

  1. Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression

    Molecular Cancer, Vol. 5